Brian R. Daley

Biography

Brian R. Daley practises in all areas of intellectual property law, with a focus on patents, trade-marks and litigation at the trial, appellate and Supreme Court level. He has particular expertise in regulatory matters and litigation involving pharmaceutical patents.

Mr. Daley also advises clients on food and drug regulation in Canada, judicial review of matters under federal jurisdiction, all aspects of trade-marks, from application through litigation, various packaging and labelling matters, including proper use of trade-marks, and compliance with language legislation on the use of English and French.

Year of Call

• Quebec Bar 1994

Year of Registration

• Canada (trade-marks) 1995
• Professional Engineer, Ontario 1986

Law School

• LL.B./B.C.L., McGill University, 1993

EDUCATION

• M.Sc., Technical University of Nova Scotia, 1985
• B.Eng., Mechanical Engineering, Memorial University, 1983

Publications

• "Mercury in Fish: Canada's Updated Risk Management Strategy" (co-author: Vanessa Rochester), Food and Drug Law Institute (FDLI ) Update, September/October 2008.
• "Bill in Parliament Proposes Changes to the Food and Drugs Act" (co-author: Rebecca Crane), Food and Drug Law Institute (FDLI ) Update, July / August 2008.
• "The State of Competition in Canada's Generic Drug Market" (co-author: Julie Jauron), Food and Drug Law Institute (FDLI) Update, May / June 2008.
• "Health Canada Adopts a Life-cycle Approach to Drug Regulation" (co-author: Jill Daley), Food and Drug Law Institute (FDLI) Update, March / April 2008.
• "Canada Seeks to Snuff Out 'Light' and 'Mild' on Tobacco Products" (co-author: Karina Kessaris), Food and Drug Law Institute (FDLI) Update, January / February 2008.
• "TransFat Regulation in Canada; Voluntary Compliance...For Now" (co-authors: Matthew Bilmes & Vanessa Rochester), Food and Drug Law Institute (FDLI) Update, November/December 2007.
• "Health Canada Reviews Changes to Clinical Trial Regulations" (co-author: Rebecca Crane), Food and Drug Law Institute (FDLI) Update, September / October 2007.
• "Supplying Generic Drugs to Developing Countries - an Overview of Canada's Regime" (co-author: Josée Gravelle), Food and Drug Law Institute (FDLI) Update, July / August 2007.
• "Pre-Trial Proceedings in Patent Infringement Actions: A Comparison among Canada, the United Kingdom, and the United States of America" (co-authors: Rachel Morgan & Kimberly Van Voorhis), American Intellectual Property Law Association (AIPLA) Quarterly Journal, Vol. 35, No. 2, Spring 2007.
• "Quebec's New Drug Policy - An Overview" (co-author: Laetitia Caporicci), Food and Drug Law Institute (FDLI) Update, May / June 2007.
• "Drug Name Confusion: Canada's Policy on Look-Alike, Sound-Alike Products," Food and Drug Law Institute (FDLI) Update, March / April 2007.
• "Importation of Drugs from Canada - Latest Developments," Food and Drug Law Institute (FDLI) Update, January / February 2007.
• "Understanding the Complex Rules Governing Chemicals" (co-authors: Jonathan Cullen & Jakub Malczewski), Food and Drug Law Institute (FDLI) Update, November / December 2006.
• "Clinical Trials and Natural Health Products" (co-author: Julie Dallaire), Food and Drug Law Institute (FDLI) Update, September / October 2006.
• "Compounding of Drugs in Canada: Whose Province Is It?, Food and Drug Law Institute (FDLI) Update, July / August 2006.
• "Labeling of GM Foods in Canada - Voluntary, For Now" (co-author: Vanessa Rochester), Food and Drug Law Institute (FDLI) Update, May / June 2006.
• "Canadian Internet Pharmacies - Are They on the Wane?", Food and Drug Law Institute (FDLI) Update, March / April 2006.
• "Listing Patents under Canada's PMNOC Regulations," Food and Drug Law Institute (FDLI) Update, January / February 2006.
• "Canadian Internet Pharmacies - Recent Developments," Food and Drug Law Institute (FDLI) Update, May / June 2005.
• "Proposed Changes to Canada's Patented Medicines (Notice of Compliance) Regulations - Mixed News for Innovative Drug Companies" (co-author: Andy Radhakant), Food and Drug Law Institute (FDLI) Update, March / April 2005.
• "Purchases of Prescription Drugs from Canadian Internet Pharmacies: The Canadian Legal Regime," Food and Drug Law Institute (FDLI) Update, No. 4, July / August 2004.
• "The Supreme Court of Canada upholds Glaxo Wellcome Inc.'s Canadian patent for AZT for use in the treatment of prophylaxis of AIDS," The Canadian Law Newsletter, American Bar Association, Fall 2003.
• Case Comment - Apotex Inc. and Novopharm Ltd v. Wellcome Foundation Ltd., Glaxo Wellcome Inc. et al, 2002 SCC 77: "The Supreme Court revisits the doctrine of sound prediction" (co-author: Jason Markwell), Intellectual Property Institute of Canada Bulletin, February 2003.
• Case Comment - United Artists Corp. v. Pink Panther Beauty Corp.: "Reduced Ambit of Protection for Famous Trademarks?", Trademark World, July 1998.

Reported Decisions

• Shire Biochem Inc. v. Canada (Health) 2008 FC 538. 
• Apotex Inc. v. Canada (Health) 2008 FC 475
• Apotex Inc. v. Merck & Co., [2007] F.C.J. No. 322
• Servier Canada Inc. v. Canada (Minister of Health), [2007] F.C.J. No. 277        
• Apotex Inc. v. Pfizer Canada Inc., [2006] F.C.A. No. 246  
• TMR Energy Ltd. v. State Property Fund of Ukraine, [2005] F.C.J. No. 1099 (F.C.A.)
• TMR Energy Ltd. v. State Property Fund of Ukraine, [2005] F.C.J. No. 116 (F.C.A.)
• Apotex Inc. v. Canada (Minister of Health) (2004), 30 C.P.R. (4th) 509 (F.C.T.D.)
• Apotex Inc. v. Merck & Co., [2004] F.C.J. No. 1495 (F.C.A.)
• Apotex Inc. v. Merck & Co., [2004] F.C.J. No. 387 (F.C.T.D.)
• Merck Frosst Canada & Co. v. Canada (Minister of Health) (2003), 25 C.P.R. (4th) 56 (F.C.T.D.)
• Apotex Inc. v. Wellcome Foundation Ltd., [2002] 4 S.C.R. 153
• Apotex Inc. v. Wellcome Foundation Ltd., [2001] F.C.J. No. 37 (F.C.A.)
• Apotex Inc. v. Wellcome Foundation Ltd. (C.A.), [2001] 1 F.C. 495 (F.C.A.)
• AstraZeneca Canada Inc. v. Canada (Minister of Health), [2001] F.C.J. No. 960 (F.C.T.D.)
• Bell Canada v. US West, Inc., [2001] F.C.J. No. 226 (F.C.T.D.)
• Merck Frosst Canada Inc. v. Canada (Minister of Health), [2001] F.C.J. No. 15 (F.C.T.D.)
• Cabot Safety Intermediate Corp. v. Minnesota Mining and Manufacturing Co., [2000] F.C.J. No. 1531 (F.C.T.D.)
• Cabot Safety Intermediate Corp. v. Minnesota Mining and Manufacturing Co., [2000] F.C.J. No. 1120 (F.C.T.D.)
• Cabot Safety Intermediate Corp. v. Minnesota Mining and Manufacturing Co., [2000] F.C.J. No. 1750 (F.C.T.D.)
• Merck & Co. v. Apotex Inc., [2000] F.C.J. No. 1811 (F.C.T.D.)
• Merck Frosst Canada & Co. v. Canada (Minister of Health), [2000] F.C.J. No. 559 (F.C.T.D.)
• Cabot Safety Intermediate Corp. v. Minnesota Mining and Manufacturing Co., [1999] F.C.J. No. 735 (F.C.T.D.)
• Merck Frosst Canada Inc. v. Canada (Minister of National Health and Welfare) (1999), 240 N.R. 195 (F.C.A.)
• Apotex Inc. v. Wellcome Foundation Ltd. (1998), 84 C.P.R. (3d) 303 (F.C.T.D.)
• Apotex Inc. v. Wellcome Foundation Ltd. (1998), 81 C.P.R. (3d) 191 (F.C.T.D.)
• Apotex Inc. v. Wellcome Foundation Ltd. (1998), 81 C.P.R. (3d) 59 (F.C.T.D.)
• Apotex Inc. v. Wellcome Foundation Ltd. (1998), 79 C.P.R. (3d) 193 (F.C.T.D.)
• Cabot Safety Intermediate Corp. v. Arkon Safety Equipment Inc.[1997] F.C.J. No. 63 (F.C.T.D.)
• Merck Frosst Canada Inc. v. Canada (Minister of Health) (1997), 76 C.P.R. (3d) 468 (F.C.T.D.)
• Cabot Safety Intermediate Corp. v. Arkon Safety Equipment Inc. (1996), 68 C.P.R. (3d) 490 (F.C.T.D.)
• Apotex Inc. v. Wellcome Foundation Ltd. (1996), 68 C.P.R. (3d) 23 (F.C.T.D.)
• Gerber Garment Technology, Inc. v. Lectra Systems of Canada (1996), 66 C.P.R. (3d) 24 (F.C.A.)

Speaking Engagements

• "Everything an IP Lawyer Needs to Know about FDA Law" (session co-ordinator), AIPLA Annual Meeting, Washington, DC: October 23, 2008.
• "Using Decision-tree Analysis to Intelligently Manage Litigation" (moderator), Association of Corporate Counsel Annual Meeting, Seattle, Washington: October 19 - 22, 2008.
• "Comparing Pharmaceutical Litigation in Canada and in the U.S." (session moderator & event Co-Chair), Joint Summer Meeting, New York State Bar Association - IP Law Section and the Intellectual Property Institute of Canada (IPIC), Montréal, Quebec: July 16 - 18, 2008.
• "Across the Border: Canadian Food & Drug Regulation and Law," Food and Drug Law Institute & FDA Annual Conference, Washington, DC: March 27, 2008.
• "The New U.S. Patent Rules: What are They and Why are they in Limbo?", Canadian Healthcare Licensing Association (CHLA) Montréal Chapter Holiday Event, Montréal, Quebec: December 13, 2007.
• "Cross-Border Discovery and Intellectual Property Litigation," New York State Bar Association - Intellectual Property Law Section in association with the Intellectual Property Institute of Canada, Ithaca, New York, August 6, 2007.
• "What an English IP/IT Lawyer Needs to Know About Canadian IP Law (and PIPEDA)", presentation to Linklaters LLP, London, England: June 27, 2007.
• "The Canadian Pharmaceutical Regulatory Regime - The Patented Medicines (Notice of Compliance Regulations and Data Protection Regulations)," presentation to Office of Technology Transfer, McGill University, Montréal, Québec: June 11, 2007.
• "What an American Intellectual Property Lawyer Needs to Know about Protecting Intellectual Property Rights in Canada," presentation to the Philadelphia Intellectual Property Law Association (PIPLA), Philadelphia, PA: March 15, 2007.
• "Recent Changes to the Patented Medicines (Notice of Compliance) Regulations and Data Protection Regulations," presentation to the Montréal Chapter of the Canadian Healthcare Licensing Association (CHLA), Montréal, Québec: December 7, 2006.
• "Civil and Criminal Options With Regard to Employee Theft or Misappropriation of Trade Secrets" (with Vanessa Rochester), American Intellectual Property Law Association (AIPLA) Annual Meeting, Washington, DC: October 19 - 21, 2006.
• "The Basics of Intellectual Property for University Technology Transfer Officers," presented to Springboard Atlantic, Charlottetown, PEI: June 28, 2005.
• "The Basics of Intellectual Property," presented on behalf of the Canadian Intellectual Property Office and the Intellectual Property Institute of Canada, to the Business Networking Club, Pointe Claire, Quebec: May 10, 2005.
• "Pharma Patent Litigation, Who is Suing Whom and Why?", Fundamentals of Pharma Patents course, Canadian Institute, Toronto, Ontario: April 19, 2005.
• "What an American Intellectual Property Lawyer needs to know about Canadian Law," presentation to the Intellectual Property Law Association of  Florida (IPLAF), Fort Lauderdale, Florida: February 22, 2005.
• "Alternatives to Litigation in the Patent Office: Strategic Use of Patent Re-examinations, Reissues, Interferences and Oppositions" (Moderator), Mid-Winter Institute, American Intellectual Property Law Association (AIPLA), Orlando, Florida: January 2005.
• "Purchases of Prescription Drugs from Canadian Internet Pharmacies," US and Canadian Pharmaceutical Policy: a Tale of Two Countries, University of Connecticut School of Law, Hartford, Connecticut: October 29, 2004.
• "Le secteur pharmaceutique dans le domaine électronique : aspects internationaux et juridiques des pharmacies Internet," Le droit et l'Internet  - meilleures pratiques et gestion préventive des risques reliés à l'Internet, Insight Information Co., Montréal, Quebec: May 2004.
• "Purchases of Prescription Drugs from Canadian Internet Pharmacies - The Canadian Legal Regime," Workshop on Fakes and Imports:  Federal and State Initiatives Concerning Counterfeit Drugs and Reimportation, Food and Drug Law Institute, Chicago, Illinois: May 2004.
• "Multinational Discovery, Home Field Advantage, Fact or Fiction," Spring Meeting of the American Intellectual Property Law Association, Atlanta, Georgia: May 2003.

Media Highlights

• Canadian Corner column in Update magazine

Memberships and Activities

• Canadian Bar Association
• Intellectual Property Institute of Canada (IPIC)
• American Intellectual Property Law Associatin (AIPLA)
• International Association for the Protection of Intellectual Property (AIPPI)
• Professional Engineers of Ontario